HYDROCHLOROTHIAZIDE
As listed in the register: HYDROCHLOROTHIAZIDE
50 mg · tablet
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Hydrochlorothiazide
- Made by
- Sanis Health Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (INZIRQO). It describes the substance, not this exact product.
Thiazides affect the renal tubular mechanisms of electrolyte reabsorption, directly increasing excretion of sodium and chloride in approximately equivalent amounts.
Indirectly, the diuretic action of hydrochlorothiazide reduces plasma volume, with consequent increases in plasma renin activity, increases in aldosterone secretion, increases in urinary potassium loss, and decreases in serum potassium.
At least 61% of the oral dose is eliminated unchanged in the urine within 24 hours.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-12-16
Safety of the active substance
From the US prescribing label for the same active substance (INZIRQO). It describes the substance, not this exact product.
- INZIRQO is contraindicated: In patients with anuria.
- In patients with hypersensitivity to hydrochlorothiazide or any ingredient in INZIRQO.
- In patients with hypersensitivity to sulfonamide-derived drugs.
- Anuria (4) Hypersensitivity to hydrochlorothiazide or any ingredient in INZIRQO (4) Hypersensitivity to sulfonamide-derived drugs (4)
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States24 matching products
Spain9 matching products
- DRINE 50 mg · comprimido
- HIDROCLOROTIAZIDA APOTEX 50 mg · comprimido
- HIDROCLOROTIAZIDA AUROVITAS 50 mg · comprimido
- HIDROCLOROTIAZIDA CINFA 50 mg · comprimido
- HIDROCLOROTIAZIDA GOBENS 50 mg · comprimido
- HIDROCLOROTIAZIDA KERN PHARMA 50 mg · comprimido
- HIDROCLOROTIAZIDA NORMON 50 mg · comprimido
- HIDROCLOROTIAZIDA STADA 50 mg · comprimido
FranceNo exact match for this strength and form
Netherlands4 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Sanis Health Inc |
|---|---|
| Active substance | Hydrochlorothiazide |
| Used in | Heart, blood pressure and circulation |
| Strength | 50 mg |
| Form | tablet |
| Classification | C03AA03 · Heart, blood pressure and circulation |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Dormant |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02360608 |
| DPD drug code | 84557 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- tablet5 products
- 12.5 mg
25 mg2
25 mg · 2 companies
50 mg2
50 mg · 2 companies
- Pro Doc Limitee
- Sanis Health Inc · this page
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.